These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14871822)

  • 1. Restoration of promyelocytic leukemia protein-nuclear bodies in neuroblastoma cells enhances retinoic acid responsiveness.
    Yu JH; Nakajima A; Nakajima H; Diller LR; Bloch KD; Bloch DB
    Cancer Res; 2004 Feb; 64(3):928-33. PubMed ID: 14871822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
    Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
    J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells.
    Petit A; Delaune A; Falluel-Morel A; Goullé JP; Vannier JP; Dubus I; Vasse M
    Pharmacol Res; 2013 Nov; 77():11-21. PubMed ID: 24004656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of promyelocytic leukemia protein increases during the differentiation of human neuroblastoma cells.
    Yu E; Choi EK; Kim CJ
    Virchows Arch; 2003 Mar; 442(3):278-83. PubMed ID: 12647219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.
    Mologni L; Marchesi E; Nielsen PE; Gambacorti-Passerini C
    Cancer Res; 2001 Jul; 61(14):5468-73. PubMed ID: 11454693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic.
    Andre C; Guillemin MC; Zhu J; Koken MH; Quignon F; Herve L; Chelbi-Alix MK; Dhumeaux D; Wang ZY; Degos L; Chen Z; de The H
    Exp Cell Res; 1996 Dec; 229(2):253-60. PubMed ID: 8986606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
    Son SH; Yu E; Choi EK; Lee H; Choi J
    Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
    Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
    Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
    Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
    Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells.
    Ohnuma-Ishikawa K; Morio T; Yamada T; Sugawara Y; Ono M; Nagasawa M; Yasuda A; Morimoto C; Ohnuma K; Dang NH; Hosoi H; Verdin E; Mizutani S
    Cancer Res; 2007 Feb; 67(3):1019-29. PubMed ID: 17283134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
    Duprez E; Lillehaug JR; Naoe T; Lanotte M
    Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells.
    Vannucchi S; Percario ZA; Chiantore MV; Matarrese P; Chelbi-Alix MK; Fagioli M; Pelicci PG; Malorni W; Fiorucci G; Romeo G; Affabris E
    Oncogene; 2000 Oct; 19(44):5041-53. PubMed ID: 11042692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
    Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
    Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
    He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
    Adamson AL; Kenney S
    J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid attenuates promyelocytic leukemia protein-induced cell death in breast cancer cells by activation of the ubiquitin-proteasome pathway.
    Son SH; Yu E; Ahn Y; Choi EK; Lee H; Choi J
    Cancer Lett; 2007 Mar; 247(2):213-23. PubMed ID: 16740359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
    Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.